Shanghai Xuerong Biotechnology Co.,Ltd. Stock

Equities

300511

CNE100002706

Fishing & Farming

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
3.45 CNY +1.77% Intraday chart for Shanghai Xuerong Biotechnology Co.,Ltd. +8.15% -35.51%

Financials

Sales 2022 2.32B 320M 438M Sales 2023 2.57B 354M 484M Capitalization 2.67B 368M 503M
Net income 2022 -287M -39.61M -54.15M Net income 2023 -188M -25.95M -35.47M EV / Sales 2022 1.88 x
Net Debt 2022 1.11B 153M 210M Net Debt 2023 1.98B 274M 374M EV / Sales 2023 1.81 x
P/E ratio 2022
-10.9 x
P/E ratio 2023
-14.1 x
Employees 2,047
Yield 2022 *
-
Yield 2023
-
Free-Float 73.95%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Approves Board Appointments CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Approves By-Election of Directors CI
Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding CI
Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million. CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution Plan for 2020, Payable on 14 May 2021 CI
Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020 CI
More news
1 day+1.77%
1 week+8.15%
Current month-16.06%
1 month-14.60%
3 months-28.12%
6 months-41.23%
Current year-35.51%
More quotes
1 week
3.07
Extreme 3.07
3.46
1 month
3.06
Extreme 3.06
4.25
Current year
2.94
Extreme 2.94
5.44
1 year
2.94
Extreme 2.94
8.10
3 years
2.94
Extreme 2.94
9.68
5 years
2.94
Extreme 2.94
20.58
10 years
2.94
Extreme 2.94
27.54
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 14-08-25
Director/Board Member 61 20-01-20
Director/Board Member 47 13-01-31
Members of the board TitleAgeSince
Chief Executive Officer 55 14-08-25
Chairman 61 11-04-30
Director/Board Member 47 22-05-26
More insiders
Date Price Change Volume
24-04-26 3.45 +1.77% 12,335,160
24-04-25 3.39 +2.11% 10,374,380
24-04-24 3.32 +2.47% 8,934,800
24-04-23 3.24 +2.21% 9,866,600
24-04-22 3.17 -0.63% 10,028,000

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Shanghai Xuerong Biotechnology Co.,Ltd. is a China-based modern agricultural company principally engaged in the production of factory cultivated agricultural products. The Company is mainly engaged in the research and development, factory cultivation and sale of fresh edible mushrooms. The Company's main products include enoki mushrooms, hypsizygus tessellatus (including beech mushrooms, white beech mushrooms and hypsizygus marmoreus) and shiitake, among others. The Company distributes its products in domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 300511 Stock